Work

Low levels of enhancer of zeste homolog 2 (EZH2) protein are prognostically adverse and independent of mutation status in acute myelogenous leukemia.

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-5259

Authors: Eduardo de Camargo Magalhaes, Samanta Catueno, Brandon Brown, Yihua Qiu, Mathilde Poplineau, Steven Kornblau

Institutions: University of Groningen, The University of Texas MD Anderson Cancer Center, Centre de Recherche en Cancérologie de Marseille

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417013108

Cites:

Cited by:

Related to: